Jeny Ghartey1, Jamie A Bastek1, Amy G Brown1, Laura Anglim1, Michal A Elovitz2. 1. Maternal-Child Health Research Program, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 2. Maternal-Child Health Research Program, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: melovitz@obgyn.upenn.edu.
Abstract
OBJECTIVE: Metabolomics has the potential to reveal novel pathways involved in the pathogenesis of preterm birth (PTB). The objective of this study was to investigate whether the cervicovaginal (CV) metabolome was different in asymptomatic women destined to have a PTB compared with term birth. STUDY DESIGN: A nested case-control study was performed using CV fluid collected from a larger prospective cohort. The CV fluid was collected between 20-24 weeks (V1) and 24-28 weeks (V2). The metabolome was compared between women with a spontaneous PTB (n = 10) to women who delivered at term (n = 10). Samples were extracted and prepared for analysis using a standard extraction solvent method. Global biochemical profiles were determined using gas chromatography/mass spectrometry and ultra-performance liquid chromatography/tandem mass spectrometry. An ANOVA was used to detect differences in biochemical compounds between the groups. A false discovery rate was estimated to account for multiple comparisons. RESULTS: A total of 313 biochemicals were identified in CV fluid. Eighty-two biochemicals were different in the CV fluid at V1 in those destined to have a PTB compared with term birth, whereas 48 were different at V2. Amino acid, carbohydrate, and peptide metabolites were distinct between women with and without PTB. CONCLUSION: These data suggest that the CV space is metabolically active during pregnancy. Changes in the CV metabolome may be observed weeks, if not months, prior to any clinical symptoms. Understanding the CV metabolome may hold promise for unraveling the pathogenesis of PTB and may provide novel biomarkers to identify women most at risk.
OBJECTIVE: Metabolomics has the potential to reveal novel pathways involved in the pathogenesis of preterm birth (PTB). The objective of this study was to investigate whether the cervicovaginal (CV) metabolome was different in asymptomatic women destined to have a PTB compared with term birth. STUDY DESIGN: A nested case-control study was performed using CV fluid collected from a larger prospective cohort. The CV fluid was collected between 20-24 weeks (V1) and 24-28 weeks (V2). The metabolome was compared between women with a spontaneous PTB (n = 10) to women who delivered at term (n = 10). Samples were extracted and prepared for analysis using a standard extraction solvent method. Global biochemical profiles were determined using gas chromatography/mass spectrometry and ultra-performance liquid chromatography/tandem mass spectrometry. An ANOVA was used to detect differences in biochemical compounds between the groups. A false discovery rate was estimated to account for multiple comparisons. RESULTS: A total of 313 biochemicals were identified in CV fluid. Eighty-two biochemicals were different in the CV fluid at V1 in those destined to have a PTB compared with term birth, whereas 48 were different at V2. Amino acid, carbohydrate, and peptide metabolites were distinct between women with and without PTB. CONCLUSION: These data suggest that the CV space is metabolically active during pregnancy. Changes in the CV metabolome may be observed weeks, if not months, prior to any clinical symptoms. Understanding the CV metabolome may hold promise for unraveling the pathogenesis of PTB and may provide novel biomarkers to identify women most at risk.
Authors: Ray O Bahado-Singh; Ranjit Akolekar; Rupasri Mandal; Edison Dong; Jianguo Xia; Michael Kruger; David S Wishart; Kypros Nicolaides Journal: J Matern Fetal Neonatal Med Date: 2012-04-28
Authors: Yujing J Heng; Megan K W Di Quinzio; Stella Liong; Michael Permezel; Gregory E Rice; Harry M Georgiou Journal: Reprod Sci Date: 2011-11-03 Impact factor: 3.060
Authors: Gonçalo Graça; Brian J Goodfellow; António S Barros; Sílvia Diaz; Iola F Duarte; Konstantina Spagou; Kirill Veselkov; Elizabeth J Want; John C Lindon; Isabel M Carreira; Eulália Galhano; Cristina Pita; Ana M Gil Journal: Mol Biosyst Date: 2012-02-01
Authors: Gregory T Spear; Audrey L French; Douglas Gilbert; M Reza Zariffard; Paria Mirmonsef; Thomas H Sullivan; William W Spear; Alan Landay; Sandra Micci; Byung-Hoo Lee; Bruce R Hamaker Journal: J Infect Dis Date: 2014-04-15 Impact factor: 5.226
Authors: Paria Mirmonsef; Anna L Hotton; Douglas Gilbert; Derick Burgad; Alan Landay; Kathleen M Weber; Mardge Cohen; Jacques Ravel; Gregory T Spear Journal: PLoS One Date: 2014-07-17 Impact factor: 3.240
Authors: Carrie E Barnum; Jennifer L Fey; Stephanie N Weiss; Guillermo Barila; Amy G Brown; Brianne K Connizzo; Snehal S Shetye; Michal A Elovitz; Louis J Soslowsky Journal: J Biomech Eng Date: 2017-06-01 Impact factor: 2.097
Authors: Kristin D Gerson; Lauren Anton; Briana Ferguson; Jacques Ravel; Heather H Burris; Michal A Elovitz Journal: J Reprod Immunol Date: 2022-05-23 Impact factor: 3.993
Authors: Ramkumar Menon; Elizabeth A Bonney; Jennifer Condon; Sam Mesiano; Robert N Taylor Journal: Hum Reprod Update Date: 2016-06-30 Impact factor: 15.610
Authors: Tracy A Manuck; Yunjia Lai; Hongyu Ru; Angelica V Glover; Julia E Rager; Rebecca C Fry; Kun Lu Journal: Am J Obstet Gynecol MFM Date: 2021-05-12
Authors: Giovanni Monni; Luigi Atzori; Valentina Corda; Francesca Dessolis; Ambra Iuculano; K Joseph Hurt; Federica Murgia Journal: Front Med (Lausanne) Date: 2021-06-25